Amiloidosis
Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50–95 years: a cross-sectional study
The Lancet Neurology Volume 16, No. 6, p435–444, June 2017 Prof Clifford R Jack Jr, MD’Correspondence information about the author...